Point72 Asia (Singapore)’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$36K Sell
1,480
-1,458
-50% -$24.3K 0.01% 624
2025
Q2
$48.3K Buy
2,938
+2,934
+73,350% +$50.7K 0.01% 594
2025
Q1
$67 Buy
+4
New +$114 ﹤0.01% 812

Other funds holding CDLX

Point72 Asia (Singapore)'s CDLX Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Cardlytics (CDLX) stake by 50% in Q3 2025, selling an estimated $24.3K and leaving 1,480 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #624.

Point72 Asia (Singapore) first reported a position in CDLX in Q1 2025 and has held it in 3 quarters since. The position peaked at $48.3K in Q2 2025. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Point72 Asia (Singapore) held 1,480 shares of Cardlytics worth $36K as of Q3 2025.
  • Point72 Asia (Singapore) sold 1,458 Cardlytics shares in Q3 2025, an estimated $24.3K.
  • Cardlytics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #624 holding.
  • Point72 Asia (Singapore) first reported a position in Cardlytics in Q1 2025 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Cardlytics position peaked at $48.3K in Q2 2025.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.